Our Team
Corami™ unites healthcare innovation experts, early-stage pharma, cardiology, and biomaterials with direct pre-clinical development and startup experience to advance intrapericardial therapeutic delivery solutions. Our multidisciplinary team integrates clinical insight, engineering rigor, and regulatory experience to design systems that localize and release therapeutics at the heart. By combining deep domain expertise with translational focus, we are deeply committed to meet cardiac therapeutic development needs and save lives.
Management Team
Esra Roan, PhD
Dr. Roan is an entrepreneur and innovator leading Corami™'s mission to advance targeted cardiac therapeutic delivery through translational science, biomaterials innovation, and strategic collaboration.
Chief Executive Officer
Dr. Doering brings extensive scientific leadership in gene therapy and therapeutic innovation, helping drive Corami™'s strategy to develop novel delivery solutions for cardiovascular disease.
Chief Scientific OfficerChris Doering, PhD
Michael B. Cooper
Michael brings more than 20 years of medical device leadership spanning R&D, product development, regulatory pathways, and product management. At Corami™, he leads product development and program management, advancing novel cardiac therapies toward clinical use.
Senior Director, PD & PMO
Gabriela Bout Denning, PhD
Dr. Bout Denning is a biotech leader with deep expertise in cell and gene therapy, and translational research guiding Corami™’s R&D programs from early discovery through clinical readiness to advance targeted therapeutic delivery for cardiovascular disease.
Senior Director, R&DBoard Members
Rifat Pamukcu, MD
Chairperson of the BoardChief Executive OfficerEsra Roan, PhD
Nate Smith
Director of Programs at Epicenter
Brian Walsh
Medical Technology ExecutiveINVENTOR
Rebecca Levit, MD | Cardiologist & Researcher, Emory University School of Medicine
Corami™ is the brainchild of Dr. Levit who practices as a Cardiologist at Emory University Hospital. In her practice, she realized that many drugs failed to achieve the therapeutic goals. As a researcher, she began to solve this problem with a novel approach of delivering therapeutics to the heart directly. In this quest, she published numerous peer-reviewed papers, received non-dilutive grants, and now serves as a clinical advisor to the Corami™’s team.
Rebecca Levit, M.D. is an Associate Professor of Medicine in the Division of Cardiology at Emory University and a practicing cardiologist. She is an internationally recognized physician-scientist whose research focuses on targeted therapeutic delivery, biomaterials, and translational cardiovascular medicine. As the inventor of Corami's foundational technology, her work is advancing new approaches to localized treatment of heart disease.
Our Advisors and Extended Team Members
Rebecca Levit, MD
Clinical Advisor, Cardiologist & Researcher Tina McArthur, PhD
Polymer Chemist, Formulation Advisor
Jonathan Nitz, MD
Clinical & Surgical Advisor, Cardiothoracic Surgeon
Hydrogel Expert, Scientific AdvisorAndres Garcia, PhD
Heather Schafer
Intellectual Property Council
Brandon Wellford
Financial Advisor
Dawn Norman
Regulatory Advisor , Partner MRC GlobalPARTNERS
Connect with Corami™.
We are building relationships with industry partners, researchers, and innovators committed to improving outcomes for patients with heart disease.
Corami™'s proprietary delivery system is designed to support the targeted delivery and retention of cardiac therapeutics, including small molecules, proteins, cell-based therapies, gene therapies, and localized treatment strategies.
If you are developing breakthrough therapies and seek novel approaches to cardiac delivery, we would welcome the opportunity to connect.